|
Vote reminder
|
2
|
Zenith Epigenetics
|
Oct 19, 2023 12:50PM
|
|
Re: Additional Exempt Distributions
|
|
Zenith Epigenetics
|
Oct 14, 2023 10:48AM
|
|
Vote Reminder
|
1
|
Zenith Epigenetics
|
Oct 14, 2023 10:47AM
|
|
Re: Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Oct 13, 2023 03:59PM
|
|
Vote Reminder
|
1
|
Zenith Epigenetics
|
Oct 10, 2023 12:24PM
|
|
Re: Vote reminder
|
|
Resverlogix Corp.
|
Oct 10, 2023 12:23PM
|
|
Vote reminder
|
3
|
Resverlogix Corp.
|
Oct 10, 2023 11:14AM
|
|
Re: Vote - please
|
|
Zenith Epigenetics
|
Oct 04, 2023 09:04PM
|
|
Re: Vote - please
|
1
|
Zenith Epigenetics
|
Oct 04, 2023 05:26PM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
4
|
Resverlogix Corp.
|
Oct 04, 2023 01:25PM
|
|
Vote - please
|
3
|
Zenith Epigenetics
|
Oct 04, 2023 01:06PM
|
|
Re: Happy 4th Anniversary
|
9
|
Resverlogix Corp.
|
Oct 01, 2023 05:47PM
|
|
Happy 4th Anniversary
|
11
|
Resverlogix Corp.
|
Sep 30, 2023 10:45AM
|
|
Re: Rumour has it
|
4
|
Resverlogix Corp.
|
Sep 08, 2023 11:39AM
|
|
Re: Middle Eastern $
|
6
|
Resverlogix Corp.
|
Sep 04, 2023 07:19PM
|
|
Middle Eastern $
|
3
|
Resverlogix Corp.
|
Sep 01, 2023 12:06PM
|
|
Happy 10th Anniversary
|
9
|
Zenith Epigenetics
|
Aug 30, 2023 08:43PM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
5
|
Resverlogix Corp.
|
Aug 30, 2023 08:05PM
|
|
Review of ZCC history
|
6
|
Zenith Epigenetics
|
Aug 27, 2023 12:06PM
|
|
Re: I believe the big/long wait
|
6
|
Resverlogix Corp.
|
Aug 23, 2023 11:44AM
|
